Repository logo
 

Monitoring the Neuroinflammatory Response Following Acute Brain injury

Published version
Peer-reviewed

Change log

Authors

Thelin, EP 
Tajsic, T 
Zeiler, FA 
Menon, DK 
Hutchinson, PJA 

Abstract

Traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) are major contributors to morbidity and mortality. Following the initial insult, patients may deteriorate due to secondary brain damage. The underlying molecular and cellular cascades incorporate components of the innate immune system. There are different approaches to assess and monitor cerebral inflammation in the neuro intensive care unit. The aim of this narrative review is to describe techniques to monitor inflammatory activity in patients with TBI and SAH in the acute setting. The analysis of pro- and anti-inflammatory cytokines in compartments of the central nervous system (CNS), including the cerebrospinal fluid and the extracellular fluid, represent the most common approaches to monitor surrogate markers of cerebral inflammatory activity. Each of these compartments has a distinct biology that reflects local processes and the cross-talk between systemic and CNS inflammation. Cytokines have been correlated to outcomes as well as ongoing, secondary injury progression. Alongside the dynamic, focal assay of humoral mediators, imaging, through positron emission tomography, can provide a global in vivo measurement of inflammatory cell activity, which reveals long-lasting processes following the initial injury. Compared to the innate immune system activated acutely after brain injury, the adaptive immune system is likely to play a greater role in the chronic phase as evidenced by T-cell-mediated autoreactivity toward brain-specific proteins. The most difficult aspect of assessing neuroinflammation is to determine whether the processes monitored are harmful or beneficial to the brain as accumulating data indicate a dual role for these inflammatory cascades following injury. In summary, the inflammatory component of the complex injury cascade following brain injury may be monitored using different modalities. Using a multimodal monitoring approach can potentially aid in the development of therapeutics targeting different aspects of the inflammatory cascade and improve the outcome following TBI and SAH.

Description

Keywords

neuroinflammation, traumatic brain injury, subarachnoid hemorrhage, multimodal monitoring, secondary brain injury

Journal Title

Frontiers in Neurology

Conference Name

Journal ISSN

1664-2295
1664-2295

Volume Title

8

Publisher

Frontiers Media
Sponsorship
Medical Research Council (G0802251)
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
Medical Research Council (MR/R005036/1)
Medical Research Council (G1002277)
European Commission (602150)
TCC (None)
Medical Research Council (G0802251/1)
Medical Research Council (G1002277/1)